{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:33Z","timestamp":1786986873877,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clinre.2021.101751","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T03:31:41Z","timestamp":1624678301000},"page":"101751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study"],"prefix":"10.1016","volume":"45","author":[{"given":"Ulrich","family":"Baumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1489-8662","authenticated-orcid":false,"given":"Ekkehard","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lacaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gonzal\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5012-8203","authenticated-orcid":false,"given":"Henrik","family":"Arnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Fischler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne H\u00f8rby","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0449-4138","authenticated-orcid":false,"given":"Mats","family":"Ekelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-G\u00f6ran","family":"Gillberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Torfg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh N.","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.clinre.2021.101751_bib0001","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.3748\/wjg.v20.i28.9418","article-title":"Atypical causes of cholestasis","volume":"20","author":"Nguyen","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2021.101751_bib0002","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/hep.510290331","article-title":"Features of Alagille syndrome in 92 patients: frequency and relation to prognosis","volume":"29","author":"Emerick","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2021.101751_bib0003","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2021.101751_bib0004","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep4.1168","article-title":"Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies","volume":"2","author":"Bull","year":"2018","journal-title":"Hepatol Commun"},{"issue":"suppl 2","key":"10.1016\/j.clinre.2021.101751_bib0005","first-page":"818","article-title":"Systematic literature review of the effect of partial external biliary diversion surgery on clinical and biochemical outcomes in progressive familial intrahepatic cholestasis patients [abstract H-P-091]","volume":"66","author":"Verkade","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.clinre.2021.101751_bib0006","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00383-014-3559-x","article-title":"Outcome of partial internal biliary diversion for intractable pruritus in children with cholestatic liver disease","volume":"30","author":"Ramachandran","year":"2014","journal-title":"Pediatr Surg Int"},{"issue":"5","key":"10.1016\/j.clinre.2021.101751_bib0007","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00383-020-04641-z","article-title":"Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients","volume":"36","author":"Foroutan","year":"2020","journal-title":"Pediatr Surg Int."},{"issue":"5","key":"10.1016\/j.clinre.2021.101751_bib0008","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.29019","article-title":"Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2021.101751_bib0009","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jpedsurg.2019.09.018","article-title":"Ileal exclusion for pruritus treatment in children with progressive familial intrahepatic cholestasis and other cholestatic diseases","volume":"55","author":"Van Vaisberg","year":"2020","journal-title":"J Pediatr Surg"},{"issue":"3","key":"10.1016\/j.clinre.2021.101751_bib0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2016.04.032","article-title":"Biliary atresia and other cholestatic childhood diseases: advances and future challenges","volume":"65","author":"Verkade","year":"2016","journal-title":"J Hepatol"},{"issue":"15","key":"10.1016\/j.clinre.2021.101751_bib0011","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200868150-00006","article-title":"Pathogenesis and treatment of pruritus in cholestasis","volume":"68","author":"Kremer","year":"2008","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.clinre.2021.101751_bib0012","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5500\/wjt.v6.i2.278","article-title":"Liver transplantation and the management of progressive familial intrahepatic cholestasis in children","volume":"6","author":"Mehl","year":"2016","journal-title":"World J Transplant"},{"issue":"2","key":"10.1016\/j.clinre.2021.101751_bib0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clinre.2017.08.007","article-title":"An update on the physiopathology and therapeutic management of cholestatic pruritus in children","volume":"42","author":"Thebaut","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2021.101751_bib0014","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/apt.13457","article-title":"The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation","volume":"43","author":"Graffner","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"36","key":"10.1016\/j.clinre.2021.101751_bib0015","doi-asserted-by":"crossref","first-page":"33920","DOI":"10.1074\/jbc.M306370200","article-title":"Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice","volume":"278","author":"Dawson","year":"2003","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.clinre.2021.101751_bib0016","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2340\/00015555-1246","article-title":"Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus","volume":"92","author":"Phan","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.clinre.2021.101751_bib0017","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis","volume":"95","author":"Whitington","year":"1988","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.clinre.2021.101751_bib0018","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1398-9995.2011.02577.x","article-title":"Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe","volume":"66","author":"Stalder","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.clinre.2021.101751_bib0019","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0014-5793(91)80688-Y","article-title":"The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man","volume":"284","author":"Axelson","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinre.2021.101751_bib0020","doi-asserted-by":"crossref","first-page":"11248","DOI":"10.1038\/ncomms11248","article-title":"Oude Elferink RP, Perrakis A. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling","volume":"7","author":"Keune","year":"2016","journal-title":"Nat Commun"},{"issue":"10074","key":"10.1016\/j.clinre.2021.101751_bib0021","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","article-title":"Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study","volume":"389","author":"Hegade","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clinre.2021.101751_bib0022","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41598-018-25214-0","article-title":"Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis","volume":"8","author":"Al-Dury","year":"2018","journal-title":"Sci Rep"},{"issue":"suppl 2","key":"10.1016\/j.clinre.2021.101751_bib0023","first-page":"S113","article-title":"Clinical pharmacology of odevixibat, a potent, selective ileal bile acid transport inhibitor with minimal systemic exposure [abstract 167]","volume":"69","author":"Gillberg","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2021.101751_bib0024","series-title":"Annual Meeting and Postgraduate Course of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition","article-title":"Drug-drug interaction study to evaluate the interaction of A4250 (odevixibat) with midazolam, a sensitive CYP3A4 substrate, and itraconazole, a P-gp inhibitor, in healthy adult subjects [poster]","author":"Stein","year":"2020"},{"issue":"4","key":"10.1016\/j.clinre.2021.101751_bib0025","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0016-5085(03)01199-5","article-title":"Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile","volume":"125","author":"Kurbegov","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinre.2021.101751_bib0026","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPG.0b013e31819a4e3d","article-title":"Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease","volume":"49","author":"Yang","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.clinre.2021.101751_bib0027","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MPG.0b013e3181df99d5","article-title":"Follow-up in children with progressive familial intrahepatic cholestasis after partial external biliary diversion","volume":"51","author":"Arnell","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2021.101751_bib0028","series-title":"Annual Meeting of the American Association for the Study of Liver Diseases","article-title":"Efficacy and safety of odevixibat, an ileal bile acid transporter inhibitor, in children with progressive familial intrahepatic cholestasis types 1 and 2: results from PEDFIC 1, a randomized, double-blind, placebo-controlled phase 3 trial [abstract LO4]","author":"Thompson","year":"2020"},{"issue":"1","key":"10.1016\/j.clinre.2021.101751_bib0029","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"van Wessel","year":"2020","journal-title":"J Hepatol"},{"issue":"1(suppl)","key":"10.1016\/j.clinre.2021.101751_bib0030","first-page":"85A","article-title":"Prognostic value of serum bile acids after kasai portoenterostomy in biliary atresia [abstract 137]","volume":"68","author":"Harpavat","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinre.2021.101751_bib0031","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/jhep.2002.33332","article-title":"Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome","volume":"35","author":"Emerick","year":"2002","journal-title":"Hepatology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121001303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740121001303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:03Z","timestamp":1761895863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740121001303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2210740121001303"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101751","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101751"}}